These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31249773)

  • 41. Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis.
    Bhadage CJ; Umarji HR; Shah K; Välimaa H
    Clin Oral Investig; 2013 Jun; 17(5):1375-82. PubMed ID: 22893038
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of curcumin with intralesional steroid injections in Oral Submucous Fibrosis - A randomized, open-label interventional study.
    Yadav M; Aravinda K; Saxena VS; Srinivas K; Ratnakar P; Gupta J; Sachdev AS; Shivhare P
    J Oral Biol Craniofac Res; 2014; 4(3):169-73. PubMed ID: 25737939
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modification of Heister Jaw Opener.
    Dengra S; Tiwari V; Sharma N
    J Maxillofac Oral Surg; 2016 Mar; 15(1):131-2. PubMed ID: 26929566
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of exercise therapy in managing post-radiotherapy trismus in head and neck cancer.
    Ezzat YE; Sharka RM; Huzaimi AA; Al-Zahrani KM; Abed HH
    J Taibah Univ Med Sci; 2021 Feb; 16(1):127-133. PubMed ID: 33603641
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of Prednisolone Mouthwash in Management of Grade III Oral Submucous Fibrosis: A Newer Drug Regimen.
    Datarkar A; Akare A; Tayal S
    J Maxillofac Oral Surg; 2020 Dec; 19(4):532-538. PubMed ID: 33071501
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Establishing a normal range for mouth opening: its use in screening for oral submucous fibrosis.
    Cox SC; Walker DM
    Br J Oral Maxillofac Surg; 1997 Feb; 35(1):40-2. PubMed ID: 9043002
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Maintenance of increased mouth opening in oral submucous fibrosis patient treated with nasolabial flap technique.
    Naphade M; Bhagat B; Adwani D; Mandwe R
    Case Rep Dent; 2014; 2014():842578. PubMed ID: 24716001
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The study of placentrex and hydrocortisone as an adjunct treatment in oral submucous fibrosis.
    Kisave P; Shekhar V; Babu PS; Hussaini SWU; Bhanot R; Kumar A; Tiwari RVC
    J Family Med Prim Care; 2020 May; 9(5):2469-2474. PubMed ID: 32754522
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison between Efficacy of Combined Use of Hyaluronidise and Triamcinolone versus Hyaluronidise, Triamcinolone Acetonide and Oral Colchicine in the Treatment of Oral Submucous Fibrosis.
    Mostafa MG; Khan JA; Ahmed S; Kamruzzaman M; Islam MR; Rahman MA; Alam MM; Khan L
    Mymensingh Med J; 2021 Jan; 30(1):79-84. PubMed ID: 33397855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of oral submucous fibrosis by collagenase: effects on oral opening and eating function.
    Lin HJ; Lin JC
    Oral Dis; 2007 Jul; 13(4):407-13. PubMed ID: 17577328
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of buccal fat pad in the treatment of oral submucous fibrosis: a newer method.
    Saravanan K; Narayanan V
    Int J Dent; 2012; 2012():935135. PubMed ID: 22666254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surgical management of oral submucous fibrosis in an edentulous patient: A procedural challenge.
    Mahajan AD; Tatu RJ; Shenoy NA; Sharma VS
    Natl J Maxillofac Surg; 2010 Jul; 1(2):161-3. PubMed ID: 22442590
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of oral submucous fibrosis by two different drug regimens: A comparative study.
    Krishnamoorthy B; Khan M
    Dent Res J (Isfahan); 2013 Jul; 10(4):527-32. PubMed ID: 24130591
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interventions for the management of oral submucous fibrosis.
    Fedorowicz Z; Chan Shih-Yen E; Dorri M; Nasser M; Newton T; Shi L
    Cochrane Database Syst Rev; 2008 Oct; (4):CD007156. PubMed ID: 18843745
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical efficacy of mouth exercising devices in oral submucous fibrosis: A systematic review.
    Gondivkar SM; Gadbail AR; Sarode SC; Gondivkar RS; Patil S; Gaikwad RN; Yuwanati M
    J Oral Biol Craniofac Res; 2020; 10(4):315-320. PubMed ID: 32714782
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of inter incisal mouth opening for airway maintenance in oral submucous fibrosis.
    Shah N; Shah J; Mahajan A
    J Maxillofac Oral Surg; 2012 Sep; 11(3):300-3. PubMed ID: 23997480
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extended nasolabial flaps in the management of oral submucous fibrosis.
    Borle RM; Nimonkar PV; Rajan R
    Br J Oral Maxillofac Surg; 2009 Jul; 47(5):382-5. PubMed ID: 18995935
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surgical management of oral submucous fibrosis with "Seagull-nasolabial flap" combined with short-term oral pentoxifylline for preventing relapse.
    Kholakiya Y; Jose A; Rawat A; Nagori SA; Jacob S; Roychoudhury A
    J Stomatol Oral Maxillofac Surg; 2020 Nov; 121(5):512-516. PubMed ID: 31904528
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Two wound-covering materials in the surgical treatment of oral submucous fibrosis: a clinical comparison.
    Pradhan H; Gupta H; Sinha V; Gupta S; Shashikanth M
    J Oral Biol Craniofac Res; 2012; 2(1):10-4. PubMed ID: 25756025
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Comparative Study to Evaluate Efficacy of Curcumin and Aloe Vera Gel along with Oral Physiotherapy in the Management of Oral Submucous Fibrosis: A Randomized Clinical Trial.
    Nerkar Rajbhoj A; Kulkarni TM; Shete A; Shete M; Gore R; Sapkal R
    Asian Pac J Cancer Prev; 2021 Feb; 22(S1):107-112. PubMed ID: 33576219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.